Elekta to buy Nucletron for $524M

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Elekta has signed a definitive agreement to acquire Nucletron for EUR365 million ($524.39 million U.S.) in cash. After the aquisition is completed, Elekta said it will offer radiotherapy planning and delivery technologies with the addition of Nucletron's brachytherapy treatment planning and delivery systems.

The Veenendaal, Netherlands-based Nucletron will add 1,000 new customers to Elekta’s customer base of more than 5,000, according to the companies.

Under the terms of the agreement, Elekta will acquire Nucletron on a cash and debt-free basis. The transaction, which has been approved by the board of directors of both companies, is subject to regulatory approval and is expected to close in early autumn 2011.

The acquisition is expected to be accretive to Elekta’s cash earnings within 12 months, according to the Stockholm, Sweden-based company. The transaction will be financed through existing cash on hand and available credit facilities. The pro forma business will continue to have a strong financial profile. The transaction remains subject to regulatory approval and is expected to close in early autumn.
 
BoA Merrill Lynch served as Elekta’s exclusive financial advisor on the transaction, and NautaDutilh served as its legal counsel. Jefferies International served as exclusive financial adviser to Nucletron. Allen & Overy served as Nucletron’s legal counsel.

Justine Varieur Cadet

Related Content

High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery
MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.